Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cells|March 26, 2025
A Comprehensive Exploration of the Biological Effects of Adipose-Derived Stem Cells in the Treatment of Systemic SclerosisGabriele Storti, Riccardo Foti, Roberta Foti, et al.
Diagnostics (Basel, Switzerland)|June 18, 2020
Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease ActivityCaterina Gagliano, Elisa Visalli, Mario Damiano Toro, et al.
Frontiers in Medicine|January 29, 2025
Prevalence of psoriatic arthritis in Italy: insights from the multicentric MAPSI studyTeodora Serban, Giuseppina Tramontano, Monica Pendolino, et al.
RMD Open|March 24, 2026
Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre studyValentino Paci, Alen Zabotti, Alessandro Fontanarosa, et al.
The Journal of Rheumatology|December 16, 2024
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and DiscontinuationMarco Sebastiani, Gemma Lepri, Claudia Iannone, et al.
Clinical and Experimental Rheumatology|April 3, 2026
Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational studyCaterina Vacchi, Marco Sebastiani, Antonio Carletto, et al.
Frontiers in Pharmacology|May 15, 2026
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Antonio Carletto, et al.
Frontiers in Immunology|July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Therapeutic Advances in Musculoskeletal Disease|February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA RegistryGiuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Pageof 6